Business
Holdings in Company
Holdings in Company.
About this update from Arecor Therapeutics Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 0211S\n Arecor Therapeutics PLC\n 11 November 2021\n \n \n \n \n \n TR-1: S\n \n \n tandard form for notification of major holdings\n \n \n \n \n \n \n \n \n \n \n 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached \n \n \n ii\n \n \n :\n \n \n \n \n \n \n Arecor Therapeutics plc\n \n \n \n \n \n \n \n 1b. Please indicate if the issuer is a non-UK issuer \n \n (please mark with an \"X\" if appropriate)\n \n \n \n \n \n \n Non-UK issuer\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 2. Reason for the notification \n \n (please mark the appropriate box or boxes with an \"X\")\n \n \n \n \n \n \n An acquisition or disposal of voting rights\n \n \n \n \n X\n \n \n \n \n \n \n An acquisition or disposal of financial instruments\n \n \n \n \n \n \n \n \n \n \n \n \n \n An event changing the breakdown of voting rights\n \n \n \n \n \n \n \n \n \n \n \n \n \n Other (please specify) iii:\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 3. Details of person subject to the notification obligation \n \n \n iv\n \n \n \n \n \n \n \n Name\n \n \n \n \n Dr Sarah Jennifer Howell\n \n \n \n \n \n \n City and country of registered office (if applicable)\n \n \n \n \n Saffron Walden, United Kingdom\n \n \n \n \n \n \n \n 4. Full name of shareholder(s)\n \n (if different from 3.) \n \n v\n \n \n \n \n \n \n \n Name\n \n \n \n \n \n \n \n \n \n \n \n \n \n City and country of registered office (if applicable)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 5. Date on which the threshold was crossed or reached \n \n \n vi\n \n \n :\n \n \n \n \n \n 25/10/2021\n \n \n \n \n \n \n 6. Date on which issuer notified (DD/MM/YYYY):\n \n \n \n \n 10/11/2021\n \n \n \n \n \n \n 7. Total positions of person(s) subject to the notification obligation\n \n \n \n \n \n \n \n \n \n \n \n \n \n % of voting rights attached to shares (total of 8. A)\n \n \n \n \n % of \n voting rights through \n financial instruments\n(total of 8.B 1 + 8.B 2)\n \n \n \n \n Total of both in % (8.A + 8.B)\n \n \n \n \n Total number of voting rights held in issuer (8.A + 8.B) \n \n vii\n \n \n \n \n \n \n \n Resulting situation on the date on which threshold was crossed or reached\n \n \n \n \n 3.02%\n \n \n \n \n 0.00\n \n \n \n \n 3.02%\n \n \n \n \n 840,406\n \n \n \n \n \n \n Position of previous n...